Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Pancreatic Neoplasms 1Neoplasms, Glandular and Epithelial 1Neoplasms by Histologic Type 1Leukemia, Myeloid, Acute 1Carcinoma 1BRAF V600E Mutation 1Adenocarcinoma 1

Interventions

Carboplatin 330Pemetrexed 266Cisplatin 234Docetaxel 195Paclitaxel 182Radiotherapy 181Erlotinib Hydrochloride 153pembrolizumab 147Gemcitabine 147Bevacizumab 125Drug Therapy 121Radiosurgery 115Nivolumab 112osimertinib 92durvalumab 88Gefitinib 67atezolizumab 63Vinorelbine 63Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 54anlotinib 42Immunotherapy 42Taxes 39Blood Specimen Collection 39Ipilimumab 38130-nm albumin-bound paclitaxel 38Specimen Handling 36Immune Checkpoint Inhibitors 35Radiation 34Albumin-Bound Paclitaxel 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Non-Small-Cell Lung × Cobicistat × Clear all
NCT05748093 2024-08-09

OSIBOOST 2

Maastricht University Medical Center

Phase 4 Recruiting
60 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03858491 2022-09-26

OSIBOOST

Academisch Ziekenhuis Maastricht

Phase EARLY_PHASE1 Completed
11 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡